Get the latest NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹9.81
▲0.2%1D
NAV as on 15 Sep 2025
/per year
Since Inception
▲▼
341 people have invested ₹ 40.6L in Baroda BNP Paribas Health and Wellness Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (15-Sep-25)
The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (14-Sep-25)
Fund Distribution
as on (14-Sep-25)
See fund sector allocation details as on (14-Sep-25)
Sector Allocation
as on (31-Aug-25)
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.43% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹637 Cr |
Inception Date | 27 June, 2025 |
Min Lumpsum/SIP | ₹1000/₹500 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 0% |
Risk | Very High Risk |
Baroda BNP Paribas Health and Wellness Fund Direct Growth is an equity fund. This fund was started on 27 June, 2025. The fund is managed by Sanjay Chawla. The fund could potentially beat inflation in the long-run.
Baroda BNP Paribas Health and Wellness Fund Direct Growth has given a CAGR return of -1.32% since inception.
Baroda BNP Paribas Health and Wellness Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Apollo Hospitals Enterprise Ltd, Mankind Pharma Ltd, Cipla Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 500.00. Baroda BNP Paribas Health and Wellness Fund Direct Growth has no lock in period.
Fund Manager of Baroda BNP Paribas Health and Wellness Fund Direct Growth, since 27 June 2025